https://feeds.newsfilecorp.com/company/12050 Latest news from StokedBio, as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Thu, 12 Mar 2026 14:01:26 -0400 https://www.newsfilecorp.com/images/newswire/customer-logos/12050.jpg https://feeds.newsfilecorp.com/company/12050 https://www.newsfilecorp.com/release/276657/Stoked-Bio-Licenses-Global-Rights-for-Novel-Antibiotic-from-McMaster-University Enterololin uses a novel mechanism of action to attack the infection.New treatment has potential use in Crohn's Disease.License is under existing Research and Collaboration Agreement with McMaster.Hamilton, Ontario--(Newsfile Corp. - December 4, 2025) - Stoked Bio Inc., a Canadian biotechnology company focused on the development of novel anti-infectives and cancer therapeutics, announced today it has secured an exclusive, global license from McMaster University for the patents covering...<img src="https://api.newsfilecorp.com/newsinfo/276657/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Thu, 04 Dec 2025 09:12:00 -0500 en https://www.newsfilecorp.com/release/276657